Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLA2G15 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | IL17F | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | PDS5B | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TMEM241 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | NKG7 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | LGALS8 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | KIR3DL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | TRIM51 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | REC114 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | ODAM | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |